Sonal Rajyaguru

1.6k total citations
25 papers, 1.1k citations indexed

About

Sonal Rajyaguru is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sonal Rajyaguru has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hepatology, 16 papers in Infectious Diseases and 12 papers in Epidemiology. Recurrent topics in Sonal Rajyaguru's work include Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (16 papers) and Hepatitis B Virus Studies (11 papers). Sonal Rajyaguru is often cited by papers focused on Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (16 papers) and Hepatitis B Virus Studies (11 papers). Sonal Rajyaguru collaborates with scholars based in United States, United Kingdom and Sweden. Sonal Rajyaguru's co-authors include Isabel Nájera, Sophie Le Pogam, Nick Cammack, Matthew F. McCown, Julian Symons, Vincent Lévêque, Hyunsoon Kang, Klaus Klumpp, Samir Ali and Wen-Rong Jiang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Sonal Rajyaguru

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonal Rajyaguru United States 18 728 589 550 272 191 25 1.1k
Tamara R. McBrayer United States 20 514 0.7× 809 1.4× 442 0.8× 485 1.8× 353 1.8× 47 1.3k
Meg Keilman United States 9 609 0.8× 522 0.9× 482 0.9× 319 1.2× 181 0.9× 12 1.1k
Tony Whitaker United States 17 436 0.6× 555 0.9× 410 0.7× 324 1.2× 192 1.0× 36 1.0k
Holly M. Micolochick Steuer United States 16 957 1.3× 845 1.4× 811 1.5× 489 1.8× 202 1.1× 27 1.6k
Christine Espiritu United States 17 1.1k 1.5× 810 1.4× 1.0k 1.9× 502 1.8× 163 0.9× 34 1.8k
Rakesh Tripathi United States 20 1.0k 1.4× 579 1.0× 859 1.6× 270 1.0× 61 0.3× 43 1.5k
Sophie Le Pogam United States 25 1.4k 1.9× 921 1.6× 1.2k 2.1× 497 1.8× 175 0.9× 50 2.0k
Ginette McKercher Canada 14 495 0.7× 502 0.9× 288 0.5× 196 0.7× 164 0.9× 30 982
Tsuyoshi Adachi Japan 12 694 1.0× 305 0.5× 406 0.7× 370 1.4× 177 0.9× 20 1.2k
Phillip M. Tharnish United States 17 420 0.6× 721 1.2× 404 0.7× 460 1.7× 373 2.0× 30 1.3k

Countries citing papers authored by Sonal Rajyaguru

Since Specialization
Citations

This map shows the geographic impact of Sonal Rajyaguru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonal Rajyaguru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonal Rajyaguru more than expected).

Fields of papers citing papers by Sonal Rajyaguru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonal Rajyaguru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonal Rajyaguru. The network helps show where Sonal Rajyaguru may publish in the future.

Co-authorship network of co-authors of Sonal Rajyaguru

This figure shows the co-authorship network connecting the top 25 collaborators of Sonal Rajyaguru. A scholar is included among the top collaborators of Sonal Rajyaguru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonal Rajyaguru. Sonal Rajyaguru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schoenfeld, Ryan C., David L. Bourdet, Ken A. Brameld, et al.. (2013). Discovery of a Novel Series of Potent Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B. Journal of Medicinal Chemistry. 56(20). 8163–8182. 26 indexed citations
2.
Rajyaguru, Sonal, Huiling Yang, Ross Martin, Michael D. Miller, & Hongmei Mo. (2013). Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolates. Antiviral Research. 100(2). 328–336. 1 indexed citations
3.
Dvory‐Sobol, Hadas, Thomas Schwartz, Bin Han, et al.. (2012). 1175 IN-VITRO FITNESS AND RESISTANCE ANALYSES OF NS3 MUTANTS DETECTED BY POPULATION AND DEEP SEQUENCING IN HCV PATIENTS FROM PHASE I STUDIES OF GS-9451 AND GS-9256. Journal of Hepatology. 56. S465–S465. 2 indexed citations
4.
Yang, Hanbiao, R. Hendricks, Calvin Yee, et al.. (2010). Cyclic amide bioisosterism: Strategic application to the design and synthesis of HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(15). 4614–4619. 22 indexed citations
5.
6.
Hendricks, R., Jay B. Fell, James F. Blake, et al.. (2009). Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(13). 3637–3641. 27 indexed citations
7.
Hang, Julie Q., Yanli Yang, Seth F. Harris, et al.. (2009). Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus. Journal of Biological Chemistry. 284(23). 15517–15529. 71 indexed citations
8.
Nájera, Isabel, Vincent Lévêque, Julie Q. Hang, et al.. (2009). 951 SILIBININ INHIBITS HCV REPLICATION IN VITRO. Journal of Hepatology. 50. S346–S346. 3 indexed citations
9.
McGuigan, Christopher, Sonal Rajyaguru, Sophie Le Pogam, et al.. (2009). The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4′-azidocytidine (R1479). Bioorganic & Medicinal Chemistry Letters. 19(15). 4250–4254. 51 indexed citations
10.
McCown, Matthew F., et al.. (2009). GT-1a or GT-1b Subtype-Specific Resistance Profiles for Hepatitis C Virus Inhibitors Telaprevir and HCV-796. Antimicrobial Agents and Chemotherapy. 53(5). 2129–2132. 96 indexed citations
11.
Chua, Pong Kian, Matthew F. McCown, Sonal Rajyaguru, et al.. (2009). Modulation of alpha interferon anti-hepatitis C virus activity by ISG15. Journal of General Virology. 90(12). 2929–2939. 36 indexed citations
12.
McCown, Matthew F., Sonal Rajyaguru, Sophie Le Pogam, et al.. (2008). The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 52(5). 1604–1612. 132 indexed citations
13.
Pogam, Sophie Le, Alan Kosaka, Stephan Chiu, et al.. (2008). Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients. Journal of Antimicrobial Chemotherapy. 61(6). 1205–1216. 106 indexed citations
14.
Hendricks, R., James F. Blake, Jay B. Fell, et al.. (2008). 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 19(2). 410–414. 46 indexed citations
15.
Rajyaguru, Sonal, Joseph A. Martin, Vincent Lévêque, et al.. (2007). Application of the Phosphoramidate ProTide Approach to 4‘-Azidouridine Confers Sub-micromolar Potency versus Hepatitis C Virus on an Inactive Nucleoside. Journal of Medicinal Chemistry. 50(8). 1840–1849. 78 indexed citations
16.
McCown, Matthew F., et al.. (2007). [790] IN VITRO RESISTANCE SELECTION TO THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R1479 AND TO THE PROTEASE INHIBITOR VX-950. Journal of Hepatology. 46. S297–S298. 2 indexed citations
17.
Pogam, Sophie Le, Wen-Rong Jiang, Vincent Lévêque, et al.. (2006). In vitro selected Con1 subgenomic replicons resistant to 2′-C-Methyl-Cytidine or to R1479 show lack of cross resistance. Virology. 351(2). 349–359. 101 indexed citations
18.
Pogam, Sophie Le, Hyunsoon Kang, Seth F. Harris, et al.. (2006). Selection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C Virus. Journal of Virology. 80(12). 6146–6154. 103 indexed citations
19.
Dunkley, Margaret, et al.. (2003). Pseudomonas aeruginosa-specific IgG1 and IgG2 subclasses in enhancement of pulmonary clearance following passive immunisation in the rat. FEMS Immunology & Medical Microbiology. 39(1). 37–44. 17 indexed citations
20.
Hadlock, Kenneth G., Robert G. Gish, Judy Rowe, et al.. (2001). Cross‐reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2). Journal of Medical Virology. 65(1). 23–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara R. McBrayer Breakdown of academic impact, for papers by Meg Keilman Breakdown of academic impact, for papers by Tony Whitaker Breakdown of academic impact, for papers by Holly M. Micolochick Steuer Breakdown of academic impact, for papers by Christine Espiritu Breakdown of academic impact, for papers by Rakesh Tripathi Breakdown of academic impact, for papers by Sophie Le Pogam Breakdown of academic impact, for papers by Ginette McKercher Breakdown of academic impact, for papers by Tsuyoshi Adachi Breakdown of academic impact, for papers by Phillip M. Tharnish
Rankless by CCL
2026